{{Rsnum
|rsid=3847987
|Gene=VDR
|Chromosome=12
|position=47844285
|Orientation=plus
|GMAF=0.1478
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=VDR
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 2.7 | 19.5 | 77.9
| HCB | 5.8 | 34.3 | 59.9
| JPT | 4.4 | 35.4 | 60.2
| YRI | 0.0 | 11.6 | 88.4
| ASW | 0.0 | 21.1 | 78.9
| CHB | 5.8 | 34.3 | 59.9
| CHD | 8.3 | 37.6 | 54.1
| GIH | 2.0 | 14.9 | 83.2
| LWK | 0.0 | 7.3 | 92.7
| MEX | 3.4 | 27.6 | 69.0
| MKK | 0.6 | 10.9 | 88.5
| TSI | 2.0 | 29.4 | 68.6
| HapMapRevision=28
}}[[rs3847987]] in the [[vitamin D]] pathway was associated with the time to onset of [[COPD]]. The SNP is a cytosine-to-adenine switch, and men with two copies of the adenine variant were more likely to develop COPD. The hazard ratio was 1.60, with a 95% confidence interval from 1.26 to 2.05, which was significant at P=0.005. [http://www.medpagetoday.com/MeetingCoverage/ATS/26497 news]

{{PMID Auto
|PMID=17130574
|Title=Protection from type 1 diabetes by vitamin D receptor haplotypes.
}}

{{PMID Auto
|PMID=18593774
|Title=Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}